809 related articles for article (PubMed ID: 16686359)
81. Retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germinal testis cancer.
Pizzocaro G
Eur J Surg Oncol; 1986 Mar; 12(1):25-8. PubMed ID: 3007218
[TBL] [Abstract][Full Text] [Related]
82. [A case of extragonadal germ cell tumor with inferior vena caval tumor thrombus].
Hashimoto Y; Yamagata K; Kondo Y; Hamasaki T; Tsuboi N; Akimoto M
Hinyokika Kiyo; 1999 Sep; 45(9):613-5. PubMed ID: 10540706
[TBL] [Abstract][Full Text] [Related]
83. Testicular mixed germ cell tumor with polyembryoma component in brothers.
Bakaris S; Resim S; Tunali N
Pediatr Dev Pathol; 2005; 8(1):92-7. PubMed ID: 15803215
[TBL] [Abstract][Full Text] [Related]
84. [Survival and quality of life of patients with testicular cancer].
Lugagne Delpon PM; Petit M; Houlgatte A; Droz JP
Ann Urol (Paris); 1998; 32(2):80-2. PubMed ID: 9599637
[TBL] [Abstract][Full Text] [Related]
85. Coffee grounds emesis: rare presentation of testicular cancer treated with neoadjuvant chemotherapy.
Thompson JL; Blute ML
Urology; 2004 Aug; 64(2):376-7. PubMed ID: 15302504
[TBL] [Abstract][Full Text] [Related]
86. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
Beck SD; Foster RS; Bihrle R; Donohue JP; Einhorn LH
Cancer; 2007 Sep; 110(6):1235-40. PubMed ID: 17665498
[TBL] [Abstract][Full Text] [Related]
87. Surgical management of early-stage nonseminomatous germ cell tumors of the testis.
Lieskovsky G; Weinberg AC; Skinner DG
Semin Urol; 1984 Nov; 2(4):208-16. PubMed ID: 6095395
[No Abstract] [Full Text] [Related]
88. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
[TBL] [Abstract][Full Text] [Related]
89. [A case of complete response with radiation and chemotherapy using cisplatin, etoposide and bleomycin].
Uekado Y; Touge H; Watanabe T; Inagaki T
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1865-8. PubMed ID: 7691042
[TBL] [Abstract][Full Text] [Related]
90. Salvage therapy in recurrent germ cell cancer.
Loehrer PJ
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1211-21. PubMed ID: 1663940
[TBL] [Abstract][Full Text] [Related]
91. Chemotherapy for advanced germ cell tumors.
Kondagunta GV; Motzer RJ
J Clin Oncol; 2006 Dec; 24(35):5493-502. PubMed ID: 17158534
[TBL] [Abstract][Full Text] [Related]
92. [A giant testicular tumor detected with dyspnea due to lung metastases: a case report].
Fujita K; Tsujikawa K; Murosaki N; Sugao H; Itoh Y; Takao T; Nakai Y; Miki T
Hinyokika Kiyo; 2001 Aug; 47(8):599-604. PubMed ID: 11579605
[TBL] [Abstract][Full Text] [Related]
93. [Inguinal metastasis of stage I testicular tumors].
van Ahlen H; von Stauffenberg ; Porst H; Vahlensieck W
Urologe A; 1988 Sep; 27(5):275-8. PubMed ID: 2845622
[TBL] [Abstract][Full Text] [Related]
94. [Unusual development of nonseminomatous germ cell tumors of the testis (NSGCT)].
Caty A; Depadt G; Feutry ML
Bull Cancer; 1997 Aug; 84(8):796-9. PubMed ID: 9339184
[TBL] [Abstract][Full Text] [Related]
95. A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.
Mead GM; Cullen MH; Huddart R; Harper P; Rustin GJ; Cook PA; Stenning SP; Mason M;
Br J Cancer; 2005 Jul; 93(2):178-84. PubMed ID: 15999102
[TBL] [Abstract][Full Text] [Related]
96. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
[TBL] [Abstract][Full Text] [Related]
97. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
98. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
99. [A case report: simultaneous bilateral testicular tumors with different cell types--complete response after combination chemotherapy of cisplatin and irrinotecan hydrochloride--].
Shoji S; Shima M; Usui Y; Nagata Y; Uchida T; Terachi T
Hinyokika Kiyo; 2006 Apr; 52(4):303-6. PubMed ID: 16686361
[TBL] [Abstract][Full Text] [Related]
100. Solitary skull recurrence from stage I seminomatous germ cell tumor of testis.
Spermon JR; Oyen WJ; Strijk SP; Hulsbergen-van de Kaa CA; Witjes JA
Urology; 2004 Aug; 64(2):377-9. PubMed ID: 15302506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
